Table 1 Clinical characteristics of prostate cancer patients.
Specimen Identifier | AGE | PSA | T stage | Gleason Grade |
|---|---|---|---|---|
01 ML | 58 | 1.29 | T1, N0, M0 | G 3 + 3 |
02 PH | 57 | 4.54 | T2, N0, M0 | G 3 + 3 |
03 PO | 60 | 7.3 | T1, N0, M0 | G 3 + 3 |
04 HS | 72 | 6.1 | T2, N0, M0 | G 3 + 3 |
05 FJD | 63 | 5.08 | T2, N0, M0 | G 3 + 3 |
06 PK | 74 | 10.7 | T3a, N0, M0 | G 3 + 4 |
07 PW | 69 | 3.22 | T1, N0, M0 | G 3 + 3 |
08 JL | 69 | 12 | T2, N0, M0 | G 3 + 4 |
09 CO | 55 | 6.7 | T2, N0, M0 | G 3 + 4 |
10 SP | 66 | 12 | T1, N0, M0 | G 3 + 3 |
11 AH | 69 | 11 | T1, N0, M0 | G 3 + 3 |
12 ST | 62 | 26 | T2, N0, M0 | G 4 + 5 |
13 PL | 61 | 7.4 | T3a, N0, M0 | G 4 + 3 |
14 AB | 75 | 9.52 | T1, N0, M0 | G 3 + 4 |
15 AO | 52 | 4.84 | T1, N0, M0 | G 3 + 3 |
16 WP | 85 | 26 | T2, N0, M0 | G 3 + 4 |
17 SR | 65 | 5.36 | T1, N0, M0 | G 3 + 3 |
18 KP | 69 | 7.5 | T1, N0, M0 | G 3 + 3 |
